HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sula Mazimba Selected Research
Sula Mazimba Research Topics
Disease
20
Heart Failure
11/2023 - 12/2010
4
Atrial Fibrillation
01/2024 - 09/2020
4
Cardiomyopathies (Cardiomyopathy)
10/2023 - 12/2010
3
Pulmonary Arterial Hypertension
01/2022 - 04/2019
3
Hemorrhage
11/2020 - 12/2019
2
Cardiogenic Shock
10/2022 - 11/2018
2
Cicatrix (Scar)
01/2022 - 12/2021
2
Pulmonary Hypertension
09/2021 - 11/2017
2
Hypertension (High Blood Pressure)
01/2020 - 01/2019
1
Coronary Disease (Coronary Heart Disease)
01/2024
1
Left Ventricular Dysfunction
01/2024
1
Morbid Obesity
11/2023
1
Obesity
11/2023
1
Respiratory Insufficiency (Respiratory Failure)
10/2022
1
COVID-19
10/2022
1
Gout
07/2022
1
Schistosomiasis (Bilharziasis)
04/2022
1
Pulmonary Embolism
01/2022
1
High Cardiac Output
01/2020
1
Primary Graft Dysfunction
12/2019
1
Inflammation (Inflammations)
12/2019
1
Inferior Wall Myocardial Infarction
05/2019
1
Airway Obstruction (Choking)
01/2019
1
Apnea
01/2019
1
Pulmonary Edema
01/2019
1
Stroke (Strokes)
01/2018
1
Familial Primary Pulmonary Hypertension
11/2017
1
Infections
09/2014
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2010
1
Multiple Myeloma
12/2010
1
Heart Diseases (Heart Disease)
12/2010
1
Cardiotoxicity
12/2010
Drug/Important Bio-Agent (IBA)
3
LY 165163 (PAPP)
IBA
09/2021 - 12/2016
2
Natriuretic Peptides
IBA
11/2023 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
04/2022 - 12/2019
2
Oxygen (Dioxygen)
IBA
10/2020 - 01/2019
1
Ticagrelor
IBA
01/2024
1
Clopidogrel (Plavix)
FDA Link
01/2024
1
high fluorescent intermediate II
IBA
11/2023
1
6-chloro-2-(1-piperazinyl)pyrazine (CPP)
IBA
10/2023
1
Creatinine
IBA
09/2023
1
Colchicine
FDA Link
Generic
07/2022
1
Anti-Arrhythmia Agents
IBA
03/2022
1
riociguat
IBA
01/2022
1
Gadolinium
IBA
01/2022
1
sacubitril and valsartan sodium hydrate drug combination
IBA
01/2022
1
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2022
1
Plastics
IBA
01/2022
1
Antigens
IBA
01/2020
1
Prostaglandins D
IBA
12/2019
1
4-S-(propionic acid)sulfidocyclophosphamide (PASP)
IBA
04/2019
1
Catecholamines
IBA
01/2019
1
Trastuzumab (Herceptin)
FDA Link
12/2010
1
Bortezomib (Velcade)
FDA Link
12/2010
1
Proteasome Inhibitors
IBA
12/2010
1
Dexamethasone (Maxidex)
FDA Link
Generic
12/2010
1
Anthracyclines
IBA
12/2010
1
Ubiquitin
IBA
12/2010
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
12/2010
Therapy/Procedure
12
Therapeutics
11/2023 - 12/2010
7
Heart-Assist Devices
10/2023 - 12/2016
5
Heart Transplantation (Grafting, Heart)
10/2023 - 09/2014
3
Catheters
10/2023 - 12/2016
3
Cardiac Resynchronization Therapy
09/2023 - 12/2020
3
Patient Readmission
10/2022 - 12/2016
3
Length of Stay
10/2022 - 12/2019
2
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2022 - 09/2020
2
Critical Care (Surgical Intensive Care)
01/2022 - 01/2019
1
Percutaneous Coronary Intervention
10/2022
1
Extracorporeal Membrane Oxygenation
01/2022
1
Defibrillators (Defibrillator)
12/2020
1
Stents
11/2020
1
Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2020
1
Hospital to Home Transition
03/2019
1
Perioperative Care
01/2019
1
Transplantation
12/2016